CALGB 100801 (Alliance): A phase II multi-center study of the addition of azacitidine (AZA) following allogeneic transplantation using a targeted busulfan based conditioning regimen for high risk myelodysplasia (MDS) and older patients with acute myeloid leukemia (AML)
- Citation:
- Bone Marrow Transplantation vol 50 (S1) abstr P640
- Meeting Instance:
- EBMT 2015
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3067
- Program:
- OGC
- Primary Committee:
- Transplant
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Ravi Vij
- Authors:
- Ravi Vij Vera Hars William Blum Tsiporah Shore Aaron Rapoport Thomas Shea Eva Hoke Richard Stone Paula Friedman Kouros Owzar Steven Devine
- Networks:
- Study
- CALGB-100801
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: